1,469 Shares in HCA Healthcare, Inc. $HCA Purchased by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) in the second quarter, HoldingsChannel reports. The firm bought 1,469 shares of the company’s stock, valued at approximately $573,000.

Several other institutional investors have also recently modified their holdings of the stock. State Street Corp lifted its stake in HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after buying an additional 76,039 shares in the last quarter. Capital World Investors raised its holdings in shares of HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after acquiring an additional 40,086 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after acquiring an additional 13,565 shares during the last quarter. Norges Bank acquired a new position in HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $412.27 on Wednesday. The stock’s 50-day moving average is $395.07 and its 200-day moving average is $445.35. The company has a market cap of $89.26 billion, a price-to-earnings ratio of 13.80, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter last year, the firm posted $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. Research analysts anticipate that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is 10.45%.

Analysts Set New Price Targets

Several brokerages recently issued reports on HCA. Argus reduced their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. TD Cowen dropped their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. Robert W. Baird cut their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. Finally, Truist Financial dropped their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $465.59.

Check Out Our Latest Analysis on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.